SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Super Micro Computer, Inc. engages in the distribution and manufacture of information technology solutions and other computer products. Its products include twin solutions, MP servers, GPU and coprocessor, MicroCloud, AMD solutions, power supplies, SuperServer, storage, motherboards, chassis, super workstations, accessories, SuperRack and server management products. The company was founded by Charles Liang, Yih-Shyan Liaw, Sara Liu, and Chiu-Chu Liu Liang in September 1993 and is headquartered in San Jose, CA.

Super Micro Computer Inc

Super Micro Computer is surging following a preliminary business update that highlighted a massive jump in gross margins to 15-17% and record-breaking new orders exceeding $60 billion. The community is actively debating the potential for a major short squeeze and questioning the sustainability of these margins, while bulls are focused on the stock's significant undervaluation relative to its surging demand and backlog.

NEAR Protocol is the blockchain for AI. A high-performance, AI-native platform built to power the next generation of decentralized applications and intelligent agents. It provides the infrastructure AI needs to transact, operate, and interact across Web2 and Web3. NEAR combines three core elements: User-Owned AI, which ensures agents act in users’ best interests; Intents and Chain Abstraction, which eliminate blockchain complexity for seamless, goal-driven transactions across chains; and a sharded blockchain architecture that delivers the scalability, speed, and low-cost execution needed for real-world AI and Web3 use. This integrated stack makes NEAR the foundation for building secure, user-owned, AI-native applications at internet scale.

Near

NEAR is experiencing heightened volatility as the community debates whether recent price action represents a classic liquidity trap or an accumulation phase for its AI-centric infrastructure. Investors are closely monitoring its technical performance against broader altcoin market trends, with sentiment divided between short-term bearishness and long-term conviction in its utility narrative.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

Sellas Life Sciences is currently trending as investors monitor the anticipation of the 80th clinical event in its Phase 3 REGAL trial, with heightened focus on upcoming media appearances by the CEO that have fueled speculation about trial data and potential corporate milestones. Community members remain deeply divided, with bulls pointing toward institutional accumulation and the curative potential of the company's immunotherapy platform, while bears emphasize concerns regarding trial delays, potential management dilution, and the history of the asset.

AT&T, Inc. is a holding company, which engages in the provision of telecommunications and technology services. It operates through the Communications and Latin America segments. The Communications segment offers wireless, wireline telecom, and broadband services to businesses and consumers located in the US and businesses globally. The Latin America segment provides wireless services and equipment in Mexico. The company was founded in 1983 and is headquartered in Dallas, TX.

AT&T, Inc.

AT&T Inc

AT&T is currently seeing significant downward pressure driven by speculative fears regarding competition from Starlink's satellite-based connectivity and general telecom sector volatility. Despite these concerns, many in the community view the current price drop as a value opportunity, highlighting the company's solid fiber infrastructure, consistent dividend, and potential for long-term stability.

Lowe's Companies, Inc. engages in the retail sale of home improvement products. The firm offers products for maintenance, repair, remodeling, home decorating, and property maintenance. It also provides home improvement products in the following categories: appliances, seasonal & outdoor living, lumber, lawn & garden, kitchens & bath, hardware, building materials, millwork, paint, rough plumbing, tools, electrical, flooring, and décor. The company was founded in 1946 and is headquartered in Mooresville, NC.

Lowe`s Cos., Inc.

Lowe's Companies, Inc.

Lowe's is attracting significant attention as investors balance concerns over a sluggish housing market and muted DIY demand against expectations for a potential cyclical recovery driven by lower interest rates. The community is actively debating the stock's technical setup and its potential to outpace sector peers, with sentiment split between those accumulating shares for long-term dividend growth and those closely monitoring technical support levels for a near-term bounce.

CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Health Care Benefits, Health Services, Pharmacy and Consumer Wellness, and Corporate and Other. The Health Care Benefits segment operates as a health care benefits provider. The Health Services segment offers a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations. The Corporate and Other Segment is involved in management and administrative expenses. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI.

CVS Health Corp

CVS Health is trending as investors respond to a surge in call option activity and optimistic analyst sentiment following the company's recent moves to integrate GLP-1 support programs. The community is actively discussing the firm's improved structural momentum and long-term potential as it navigates regulatory landscapes while positioning itself as a key player in coordinated care.

SoFi Technologies, Inc. is a financial service platform, which engages in the provision of student loan refinancing options to the private student loan market. It operates through the following segments: Lending, Technology Platform, and Financial Services. The Lending segment offers personal loans, student loans, home loan products, and related servicing activities. The Technology Platform segment focuses on technology products and solutions revenue. The Financial Services segment includes the SoFi Money product, SoFi Invest product, SoFi Credit Card product, SoFi Relay personal finance management product, and other financial services. The company was founded in April 2011 and is headquartered in San Francisco, CA.

SoFi Technologies Inc

SoFi is facing intense scrutiny as investors weigh solid business growth and increasing institutional accumulation against concerns regarding share dilution and historical post-earnings volatility. While some community members remain bullish on the long-term fintech ecosystem, sentiment is heavily divided as participants brace for potential price swings surrounding upcoming quarterly results.

Webull Corp. engages in the provision of financial services. It offers trading, wealth management product distribution, market data and information, user community, and investor education. The company was founded by An Quan Wang in 2016 and is headquartered in St. Petersburg, FL.

Webull Corp. - Ordinary Shares - Class A

Webull Corp

Webull Corp (BULL) is gaining significant traction as traders capitalize on the stock's recent clearance of its 200-day moving average and positive momentum following a series of analyst price target upgrades. The community is actively debating the stock's potential for a short squeeze as investors draw comparisons to other successful fintech platforms, with many bulls closely watching for a sustained breakout above key resistance levels.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bull 3X ETF

Direxion Daily Semiconductor Bull 3X Shares

SOXL is seeing intense volatility as investors react to a combination of geopolitical tensions in the Middle East and a sharp rotation out of semiconductor and AI-related stocks. Community sentiment remains deeply divided, with bulls looking to capitalize on perceived oversold conditions and potential rebounds in memory chip stocks, while bears point to broader economic risks and signs of a bubble bursting.

Nu Holdings Ltd. is a holding company, which engages in the provision of digital banking services. The company was founded by David Vélez Osorno, Cristina Helena Zingaretti Junqueira, and Adam Edward Wible on February 26, 2016 and is headquartered in São Paulo, Brazil.

Nu Holdings Ltd - Ordinary Shares Class A

Nu Holdings Ltd

Nu Holdings is facing volatility despite reporting its strongest quarter in history, with community discussion centered on whether the post-earnings dip represents a prime accumulation opportunity or a signal of deeper credit risk. While some investors are highlighting the company's hyper-growth and successful expansion into new markets, others remain concerned about rising delinquency provisions and the company's decision to aggressively scale its unsecured lending portfolio.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Is ADMA Stock's 13.5% Monthly Gain a Sign of Recovery? 

ADMA shares rebound 13.5% in a month after a steep decline, even as lowered 2026 guidance and IG market competition continue to weigh on sentiment.

Grifols, S.A. (GRFS) Sees Strong Biopharma Growth Led by Gamunex and Yimmugo

Grifols, S.A. (GRFS) Sees Strong Biopharma Growth Led by Gamunex and Yimmugo...

Can Asceniv Help ADMA Navigate the Current IG Market Challenges? 

ADMA faces IG pricing pressure and reduced 2026 guidance, but Asceniv demand remains strong amid resilient patient utilization.

Will the IG Market Challenges Affect ADMA Biologics Prospects in 2026?

ADMA cuts 2026 guidance after weak Bivigam sales and IG market pressure weigh on revenues amid rising competition and order volatility.

Is it Time to Exit ADMA Biologics Stock After a 22% Monthly Plunge?

ADMA shares plunge after the company cuts 2026 guidance, citing pricing pressure, rising competition and elevated IG channel inventories.

Will the Label Expansion of Asceniv Boost ADMA's Top-Line Growth? 

ADMA stock in focus after FDA expands Asceniv's label to younger patients, boosting market reach and growth outlook amid rising demand.

Wall Street Zen Downgrades Grifols (NASDAQ:GRFS) to Hold

Wall Street Zen cut shares of Grifols from a "buy" rating to a "hold" rating in a research report on Saturday...

Grifols (GRFS) to Release Earnings on Thursday

Grifols (NASDAQ:GRFS) will be releasing its Q1 2026 earnings on Thursday, April 30. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-4-30-grifols-sa-stock...

Will Asceniv Deliver for ADMA in the Upcoming Quarterly Results?

ADMA banks on surging Asceniv demand to sustain growth, supported by expanded plasma supply and broader coverage, which should drive continued gains into 2026.

Does ADMA Biologics' Growth Story Outweigh Short-Seller Concerns?

ADMA stock slides after a short report sparks volatility, but management pushes back, citing strong Asceniv demand and steady fundamentals.

Grifols SA is a global specialty plasma therapeutics company that engages in the development, manufacturing, and distribution of a broad range of biological medicines based on plasma-derived proteins. It operates through the following segments: Biopharma, Diagnostic, Bio Supplies, and Others. The Biopharma Segment includes all activities related with products deriving from human plasma for therapeutic use. The Diagnostic Segment deals with the marketing of diagnostic testing equipment, reagents, and other equipment. The Bio Supplies segment consists of all transactions related to biological products for non-therapeutic use. The Others segment focuses on the rendering of manufacturing services to third party companies. The company was founded by José Antonio Grifols i Roig in 1909 and is headquartered in Barcelona, Spain.

Grifols SA - ADR - Level III

Bullish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Feed

News

Sentiment

Earnings

Fundamentals

Info

GRFSGrifols, SA

Fundamentals

Latest GRFS News